STOCK TITAN

TILT Holdings Announces Appointment of Gary Santo to National Cannabis Roundtable Board of Directors

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
management
Rhea-AI Summary

TILT Holdings Inc. announced that its CEO, Gary Santo, has joined the Board of Directors of the National Cannabis Roundtable (NCR). This non-partisan alliance focuses on advancing cannabis policy in the U.S. Santo emphasized the ongoing challenges in cannabis reform, particularly the recent failure of the SAFE Banking Act in Congress, which highlights the need for continued advocacy for financial access and the elimination of tax barriers for cannabis businesses. TILT aims to support legislative efforts for decriminalization, consumer safety, and social equity.

Positive
  • Gary Santo's appointment to NCR may enhance TILT's advocacy efforts in cannabis policy.
  • TILT’s involvement with NCR could facilitate improved access to financial services for cannabis businesses.
Negative
  • The failure of the SAFE Banking Act illustrates ongoing regulatory challenges for cannabis companies.
  • Concerns about the effectiveness of TILT's legislative advocacy in a complex political landscape.

PHOENIX, Jan. 12, 2023 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT” or the “Company”) (NEO: TILT) (OTCQX: TLLTF), a global provider of cannabis business solutions that include inhalation technologies, cultivation, manufacturing, processing, brand development and retail, today announced its Chief Executive Officer (“CEO”) Gary Santo has been appointed to the Board of Directors of the National Cannabis Roundtable (“NCR”). Founded in 2019, NCR is a non-partisan alliance of cannabis companies and ancillary services and solutions providers working to advance cannabis policy in the United States.

“The National Cannabis Roundtable has been and continues to be at the forefront of federal cannabis policy,” said Gary Santo, TILT’s CEO. “While the industry made some important gains, including a presidential pardon of all federal convictions for simple possession of marijuana and the review of the scheduling of cannabis under federal law, unfortunately, the SAFE Banking Act failed to pass Congress. The failure of the SAFE Banking Act to pass the Senate shows once again there is still more work to be done. As a member of the NCR, TILT will continue to advocate for access to traditional financial services and capital markets for cannabis businesses, as well as the elimination of tax barriers such as 280E.”

Continued Santo, “TILT will fully support NCR’s legislative priorities around decriminalizing cannabis, maintaining business continuity, ensuring consumer and worker safety, promoting social equity, and remediating harms from prohibition.”

“There is a tremendous amount of work to be done and a steep learning curve when it comes to cannabis reform,” said NCR Executive Director Saphira Galoob. “Each member brings a unique perspective to NCR’s advocacy efforts, and we look forward to having TILT represented on our leadership team.”

To keep up-to-date on progress, follow TILT and NCR on social media:

     
 • LinkedIn: @tiltholdings @nationalcannabisroundtable
 • Twitter: @TILT_Holdings
  @FollowNCR
     

About TILT
TILT helps cannabis businesses build brands. Through a portfolio of companies providing technology, hardware, cultivation and production, TILT services brands and cannabis retailers across 39 states in the U.S., as well as Canada, Israel, South America and the European Union. TILT’s core businesses include Jupiter Research LLC, a wholly-owned subsidiary and leader in the vaporization segment focused on hardware design, research, development and manufacturing; and cannabis operations, Commonwealth Alternative Care, Inc. in Massachusetts, Standard Farms LLC in Pennsylvania, Standard Farms Ohio, LLC in Ohio, and its partnership with the Shinnecock Indian Nation in New York. TILT is headquartered in Phoenix, Arizona. For more information, visit www.tiltholdings.com.

Forward-Looking Information
This news release contains forward-looking information and statements (together, “forward-looking information”) under applicable Canadian and U.S. securities laws which are based on current expectations. Forward-looking information is provided for the purpose of presenting information about TILT management’s current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. Forward looking information may include, without limitation, the opinions or beliefs of management, prospects, opportunities, priorities, targets, goals, ongoing objectives, milestones, strategies, and outlook of TILT, and includes statements about, among other things, future developments, and the future operations, strengths and strategy of TILT. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “will”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. These statements should not be read as guarantees of future performance or results. These statements are based upon certain material factors, assumptions and analyses that were applied in drawing a conclusion or making a forecast or projection, including TILT’s experience and perceptions of historical trends, the ability of TILT to maximize shareholder value, current conditions and expected future developments, as well as other factors that are believed to be reasonable in the circumstances.

Although such statements are based on management’s reasonable assumptions at the date such statements are made, there can be no assurance that it will be completed on the terms described above and that such forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such forward-looking information. Accordingly, readers should not place undue reliance on the forward-looking information. TILT assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by applicable law.

By its nature, forward-looking information is subject to risks and uncertainties, and there are a variety of risk factors, many of which are beyond the control of TILT, and that may cause actual outcomes to differ materially from those discussed in the forward-looking information. Such risk factors include, but are not limited to, those described under the heading “Risk Factors” in Amendment No. 2 to the Form 10 Registration Statement and “Item 1A Risk Factors” in the Quarterly Report on Form 10-Q for the quarter ended September 30, 2022, in each case, as filed by TILT with the United States Securities and Exchange Commission and on SEDAR at www.sedar.com.

Company Contact:
Lynn Ricci, VP of Investor Relations & Corporate Communications
TILT Holdings Inc.
lricci@tiltholdings.com

Media Contact:
TILT
Leland Radovanovic
Trailblaze
TILT@trailblaze.co
845-200-5249


FAQ

What recent leadership change occurred at TILT Holdings?

Gary Santo, the CEO of TILT Holdings, was appointed to the Board of Directors of the National Cannabis Roundtable on January 12, 2023.

What is the National Cannabis Roundtable?

The National Cannabis Roundtable is a non-partisan alliance established to advocate for cannabis policy reform and address issues affecting the cannabis industry in the U.S.

How might TILT's involvement with NCR affect its business?

TILT's participation in NCR is expected to strengthen its advocacy for better financial services and legislative reforms in the cannabis sector.

What challenges is TILT facing in cannabis reform?

The failure of the SAFE Banking Act to pass Congress indicates ongoing obstacles for cannabis businesses, affecting access to financial services.

TILT HLDGS INC

OTC:TLLTF

TLLTF Rankings

TLLTF Latest News

TLLTF Stock Data

2.87M
319.43M
7.94%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Phoenix